| 000 | 01606 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517135729.0 | ||
| 264 | 0 | _c20180220 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1874-4729 | ||
| 024 | 7 |
_a10.2174/1874471010666170126143636 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFaintuch, Bluma Linkowski | |
| 245 | 0 | 0 |
_aEvaluation of the Influence of the Conjugation Site of the Chelator Agent HYNIC to GLP1 Antagonist Radiotracer for Insulinoma Diagnosis. _h[electronic resource] |
| 260 |
_bCurrent radiopharmaceuticals _c2017 |
||
| 300 |
_a65-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aChelating Agents _xpharmacology |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aInsulinoma _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdiagnostic imaging |
| 650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacology |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aTechnetium _xpharmacology |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aSeo, Daniele | |
| 700 | 1 | _ade Oliveira, Erica Aparecida | |
| 700 | 1 | _aTargino, Roselaine Campos | |
| 700 | 1 | _aMoro, Ana Maria | |
| 773 | 0 |
_tCurrent radiopharmaceuticals _gvol. 10 _gno. 1 _gp. 65-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1874471010666170126143636 _zAvailable from publisher's website |
| 999 |
_c26853354 _d26853354 |
||